Rhythm Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Rhythm Pharmaceuticals Inc.: Is Infosys Ltd. worth buying?
Item: Rhythm Pharmaceuticals Inc.
Rating: 1.531541625
Author: Trendlyne DVM scores

Momentum Trap

about

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, in...

106.28 1.39 (1.33%)

131.55% Gain from 52W Low

93,236

XNAS Volume

XNAS 13 Jan, 2026 11:36 AM (EST)

Low Financial Strength

33.3 / 100

Expensive Valuation

4.7 / 100

Technically Neutral

51.2 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

140

1Yr Price target upside is 32%

14 analysts

Rhythm Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Rhythm Pharma Inc Live Stock Price Today, Share Analysis and Chart

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, in...

131.55% Gain from 52W Low

SWOT Analysis

Rhythm Pharma Inc Live Price Chart